IP Library Granted Patent US 7,960,348
Granted Patent B2
US 7,960,348 · App. 12/158,251 · Granted Jun 14, 2011

Metastin derivatives and use thereof

Assignee: Takeda Pharmaceutical Company Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,348
App. No.
12/158,251
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention provides stable metastin derivatives having excellent biological activities (a cancer metastasis suppressing activity, a cancer growth suppressing activity, a gonadotropic hormone secretion stimulating activity, sex hormone secretion stimulating activity, etc.). By substituting the constituent amino acids of metastin with specific amino acids in the metastin derivative of the present invention, blood stability, solubility, etc. are more improved, gelation tendency is reduced, pharmacokinetics are also improved, and an excellent cancer metastasis suppressing activity or a cancer growth suppressing activity is exhibited. Furthermore, the metastin derivative of the present invention has the effects of suppressing gonadotropic hormone secretion, suppressing sex hormone secretion, etc.

Claims (2)

1. Ac-D-Tyr-Hyp-Asn-Thr-Phe-AzaGly-Leu-Arg(Me)-Trp-NH 2 or a salt thereof.

2. A medicament comprising the compound according to claim 1 or a salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2008
From: ASAMI, TAIJI; NISHIZAWA, NAOKI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 021724/0566 →
Priority Claims (2)
JP 2005-370388 · Dec 22, 2005 · national
JP 2006-275843 · Oct 6, 2006 · national
Continuity (1)
Related Publication 20100331520A1 · Dec 30, 2010